Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASEPTIC: Co-trimoxazole for primary prophylaxis of spontaneous bacterial peritonitis in cirrhosis
2019-000581-38Phase 3Unknown
- Sponsor
- University College London Comprehensive Clinical Trials Unit
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary peritonitis, Cirrhosis and ascites comparing Co-trimoxazole prophylaxis with Placebo (2 arms). Primary endpoint: Time to first spontaneous bacterial peritonitis episode. Status: unknown.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
primary peritonitisCirrhosisascites
Beyond the preview
Go deeper on 2019-000581-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000581-38.